Multi-regional

2775998 D9WC3N3V 2026 1 padagogische-hochschule-bern-institut-vorschulstufe-und-primarstufe 50 date desc year 4531 https://www.iedea.org/wp-content/plugins/zotpress/

2775998 D9WC3N3V 2025 1 padagogische-hochschule-bern-institut-vorschulstufe-und-primarstufe 50 date desc year 4531 https://www.iedea.org/wp-content/plugins/zotpress/

2024

Zaniewski, E. et al. (2024). Transition to dolutegravir-based ART in 35 low- and middle-income countries: a global survey of HIV care clinics. AIDS. https://doi.org/10.1097/QAD.0000000000004007.

Yotebieng, M. et al. (2024). Accuracy of nine-item Patient Health Questionnaire against psychiatric diagnosis for depression among people with HIV. AIDS 38, 1765–1773. http://doi.org/10.1097/QAD.0000000000003963.

Plaisy, M. K. et al. (2024). Metabolic causes of liver disease among adults living with HIV from low- and middle-income countries: a cross-sectional study. J Int AIDS Soc 27, e26238. http://doi.org/10.1002/jia2.26238.

Parcesepe, A. M. et al. (2024). Prevalence and co-occurrence of symptoms of mental and substance use disorders among people with HIV age 40 and older in low- and middle-income countries: a cross-sectional study. J Int AIDS Soc 27, e26359. http://doi.org/10.1002/jia2.26359.

Lancaster, K. E. et al. (2024). Availability of substance use screening and treatment within HIV clinical sites across seven geographic regions within the IeDEA consortium. Int J Drug Policy 124, 104309. http://doi.org/10.1016/j.drugpo.2023.104309.

Kebede, S. et al. (2024). Preexposure prophylaxis availability among health facilities participating in the global International epidemiology Databases to Evaluate AIDS (IeDEA) consortium. AIDS 38, 751–756. http://doi.org/10.1097/QAD.0000000000003824.

Enane, L. A. et al. (2024). The Tuberculosis Sentinel Research Network (TB-SRN) of the International epidemiology Databases to Evaluate AIDS (IeDEA): protocol for a prospective cohort study in Africa, Southeast Asia and Latin America. BMJ Open 14, e079138. http://doi.org/10.1136/bmjopen-2023-079138.

Egger, M. et al. (2024). HIV-1 subtype-specific drug resistance on dolutegravir-based antiretroviral therapy: protocol for a multicentre study (DTG RESIST). BMJ Open 14, e085819. http://doi.org/10.1136/bmjopen-2024-085819.

Davidović, M. et al. (2024). Facility-Based Indicators to Manage and Scale Up Cervical Cancer Prevention and Care Services for Women Living With HIV in Sub-Saharan Africa: a Three-Round Online Delphi Consensus Method. J Acquir Immune Defic Syndr 95, 170–178. http://doi.org/10.1097/QAI.0000000000003343.

Carlucci, J. G. et al. (2024). High Prevalence of Unconfirmed Positive HIV Polymerase Chain Reaction Test Results Among African Infants With HIV Exposure in the International Epidemiology Databases to Evaluate AIDS Consortium. Clin Infect Dis 79, 1475–1478. http://doi.org/10.1093/cid/ciae251.

Brazier, E. et al. (2024). Long-term HIV care outcomes under universal HIV treatment guidelines: A retrospective cohort study in 25 countries. PLoS Med 21, e1004367. http://doi.org/10.1371/journal.pmed.1004367.

Asangbeh-Kerman, S. L. et al. (2024). Cervical cancer prevention and care in HIV clinics across sub-Saharan Africa: results of a facility-based survey. J Int AIDS Soc 27, e26303. http://doi.org/10.1002/jia2.26303.

2023

Zwyer, M. et al. (2023). Back-to-Africa introductions of Mycobacterium tuberculosis as the main cause of tuberculosis in Dar es Salaam, Tanzania. PLoS Pathog 19, e1010893. http://doi.org/10.1371/journal.ppat.1010893.

Vreeman, R. C. et al. (2023). Global HIV prevention, care and treatment services for children: a cross-sectional survey from the International Epidemiology Databases to Evaluate AIDS (IeDEA) consortium. BMJ Open 13, e069399. http://doi.org/10.1136/bmjopen-2022-069399.

Ross, J. et al. (2023). Same-Day Antiretroviral Therapy Initiation as a Predictor of Loss to Follow-up and Viral Suppression Among People With Human Immunodeficiency Virus in Sub-Saharan Africa. Clin Infect Dis 76, 39–47. http://doi.org/10.1093/cid/ciac759.

Person, A. K. et al. (2023). Cryptococcal Meningitis and Clinical Outcomes in Persons With Human Immunodeficiency Virus: A Global View. Clin Infect Dis 76, 2116–2125. http://doi.org/10.1093/cid/ciad076.

Parcesepe, A. M. et al. (2023). Availability of screening and treatment for common mental disorders in HIV clinic settings: data from the global International epidemiology Databases to Evaluate AIDS (IeDEA) Consortium, 2016-2017 and 2020. J Int AIDS Soc 26, e26147. http://doi.org/10.1002/jia2.26147.

Humphrey, J. et al. (2023). Integration of HIV care into maternal and child health services in the global IeDEA consortium. Front Glob Womens Health 4, 1066297. http://doi.org/10.3389/fgwh.2023.1066297.

Brazier, E. et al. (2023). Design and implementation of a global site assessment survey among HIV clinics participating in the International epidemiology Databases to Evaluate AIDS (IeDEA) research consortium. PLoS One 18, e0268167. http://doi.org/10.1371/journal.pone.0268167.

2022

Zurcher, K. et al. (2022). Integrating services for HIV and multidrug-resistant tuberculosis: A global cross-sectional survey among ART clinics in low- and middle-income countries. PLOS Glob Public Health 2, e0000180. http://doi.org/10.1371/journal.pgph.0000180.

Walker, T. M. et al. (2022). The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: A genotypic analysis. Lancet Microbe 3, e265–e273. http://doi.org/10.1016/S2666-5247(21)00301-3.

Wada, P. Y. et al. (2022). Site-Level Comprehensiveness of Care Is Associated with Individual Clinical Retention Among Adults Living with HIV in International Epidemiology Databases to Evaluate AIDS, a Global HIV Cohort Collaboration, 2000-2016. AIDS Patient Care STDS 36, 343–355. http://doi.org/10.1089/apc.2022.0042.

Romo, M. L. et al. (2022). Disparities in Dolutegravir Uptake Affecting Females of Reproductive Age With HIV in Low- and Middle-Income Countries After Initial Concerns About Teratogenicity : An Observational Study. Ann Intern Med 175, 84–94. http://doi.org/10.7326/M21-3037.

Romo, M. L. et al. (2022). Real-world use and outcomes of dolutegravir-containing antiretroviral therapy in HIV and tuberculosis co-infection: a site survey and cohort study in sub-Saharan Africa. J Int AIDS Soc 25, e25961. http://doi.org/10.1002/jia2.25961.

Marti, M. et al. (2022). Impact of the COVID-19 pandemic on TB services at ART programmes in low- and middle-income countries: a multi-cohort survey. J Int AIDS Soc 25, e26018. http://doi.org/10.1002/jia2.26018.

Lewis, J. T. et al. (2022). The IeDEA harmonist data toolkit: A data quality and data sharing solution for a global HIV Research consortium. J Biomed Inform 131, 104110. http://doi.org/10.1016/j.jbi.2022.104110.

Justice, A. C. et al. (2022). Delayed presentation of HIV among older individuals: a growing problem. Lancet HIV 9, e269–e280. http://doi.org/10.1016/S2352-3018(22)00003-0.

Edmonds, A. et al. (2022). Clinical and programmatic outcomes of HIV-exposed infants enrolled in care at geographically diverse clinics, 1997-2021: A cohort study. PLoS Med 19, e1004089. http://doi.org/10.1371/journal.pmed.1004089.

Collaborative Initiative for Paediatric et al. (2022). Growth and CD4 patterns of adolescents living with perinatally acquired HIV worldwide, a CIPHER cohort collaboration analysis. J Int AIDS Soc 25, e25871. http://doi.org/10.1002/jia2.25871.

Brazier, E. et al. (2022). Service delivery challenges in HIV care during the first year of the COVID-19 pandemic: results from a site assessment survey across the global IeDEA consortium. J Int AIDS Soc 25, e26036. http://doi.org/10.1002/jia2.26036.

Antimycobacterial Susceptibility Testing Group. (2022). Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment. Eur Respir J 59, 2200166. http://doi.org/10.1183/13993003.00166-2022.

2021

Zurcher, K. et al. (2021). Mortality from drug-resistant tuberculosis in high-burden countries comparing routine drug susceptibility testing with whole-genome sequencing: a multicentre cohort study. Lancet Microbe 2, e320–e330. http://doi.org/10.1016/S2666-5247(21)00044-6.

Tsondai, P. R. et al. (2021). Improving Methods to Classify Perinatal versus Nonperinatal HIV Acquisition in Young Adolescents 10-14 Years of Age. Pediatr Infect Dis J 40, 453–456. http://doi.org/10.1097/INF.0000000000003059.

McMahon, D. E. et al. (2021). Global Disparities in Skin Cancer Services at HIV Treatment Centers across 29 Countries. J Invest Dermatol 141, 2533-2536 e2. http://doi.org/10.1016/j.jid.2021.02.758.

Kassanjee, R. et al. (2021). Global HIV mortality trends among children on antiretroviral treatment corrected for under-reported deaths: an updated analysis of the International epidemiology Databases to Evaluate AIDS collaboration. J Int AIDS Soc 24 Suppl 5, e25780. http://doi.org/10.1002/jia2.25780.

Johnson, L. F. et al. (2021). Achieving consistency in measures of HIV-1 viral suppression across countries: derivation of an adjustment based on international antiretroviral treatment cohort data. J Int AIDS Soc 24 Suppl 5, e25776. http://doi.org/10.1002/jia2.25776.

Iyun, V. et al. (2021). Variations in the characteristics and outcomes of children living with HIV following universal ART in sub-Saharan Africa (2006-17): a retrospective cohort study. Lancet HIV 8, e353–e362. http://doi.org/10.1016/S2352-3018(21)00004-7.

Han, W. M. et al. (2021). Global estimates of viral suppression in children and adolescents and adults on antiretroviral therapy adjusted for missing viral load measurements: a multiregional, retrospective cohort study in 31 countries. Lancet HIV 8, e766–e775. http://doi.org/10.1016/S2352-3018(21)00265-4.

Desmonde, S. et al. (2021). Age-specific mortality rate ratios in adolescents and youth aged 10-24 years living with perinatally versus nonperinatally acquired HIV. AIDS 35, 625–632. http://doi.org/10.1097/QAD.0000000000002765.

Brazier, E. et al. (2021). Effects of National Adoption of Treat-All Guidelines on Pre-Antiretroviral Therapy (ART) CD4 Testing and Viral Load Monitoring After ART initiation: A Regression Discontinuity Analysis. Clin Infect Dis 73, e1273–e1281. http://doi.org/10.1093/cid/ciab222.

2020

Tymejczyk, O. et al. (2020). Impact of Universal Antiretroviral Treatment Eligibility on Rapid Treatment Initiation Among Young Adolescents with Human Immunodeficiency Virus in Sub-Saharan Africa. J Infect Dis 222, 755–764. http://doi.org/10.1093/infdis/jiz547.

Rohner, E. et al. (2020). Cervical cancer risk in women living with HIV across four continents: A multicohort study. Int J Cancer 146, 601–609. http://doi.org/10.1002/ijc.32260.

Reichmuth, M. L. et al. (2020). Natural Polymorphisms in Mycobacterium tuberculosis Conferring Resistance to Delamanid in Drug-Naive Patients. Antimicrob Agents Chemother 64. http://doi.org/10.1128/AAC.00513-20.

Rebeiro, P. F. et al. (2020). Implications of COVID-19 for HIV Research: data sources, indicators and longitudinal analyses. J Int AIDS Soc 23, e25627. http://doi.org/10.1002/jia2.25627.

Patten, G. et al. (2020). Raltegravir use and outcomes among children and adolescents living with HIV in the IeDEA global consortium. J Int AIDS Soc 23, e25580. http://doi.org/10.1002/jia2.25580.

Parcesepe, A. M. et al. (2020). Substance use service availability in HIV treatment programs: Data from the global IeDEA consortium, 2014-2015 and 2017. PLoS One 15, e0237772. http://doi.org/10.1371/journal.pone.0237772.

Loiseau, C. et al. (2020). HIV Coinfection Is Associated with Low-Fitness rpoB Variants in Rifampicin-Resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 64. http://doi.org/10.1128/AAC.00782-20.

Jesson, J. et al. (2020). Weight-for-age distributions among children with HIV on antiretroviral therapy in the International epidemiology Databases to Evaluate AIDS (IeDEA) multiregional consortium. BMC Res Notes 13, 249. http://doi.org/10.1186/s13104-020-05081-7.

IeDEA and COHERE in EuroCoord Cohort Collaboration. (2020). All-cause mortality after antiretroviral therapy initiation in HIV-positive women from Europe, Sub-Saharan Africa and the Americas. AIDS 34, 277–289. http://doi.org/10.1097/QAD.0000000000002399.

Humphrey, J. M. et al. (2020). Mortality Among People With HIV Treated for Tuberculosis Based on Positive, Negative, or No Bacteriologic Test Results for Tuberculosis: The IeDEA Consortium. Open Forum Infect Dis 7, ofaa006. http://doi.org/10.1093/ofid/ofaa006.

Harezlak, J. et al. (2020). PS-SiZer map to investigate significant features of body-weight profile changes in HIV infected patients in the IeDEA Collaboration. PLoS One 15, e0220165. http://doi.org/10.1371/journal.pone.0220165.

Desmonde, S. et al. (2020). Time-varying age- and CD4-stratified rates of mortality and WHO stage 3 and stage 4 events in children, adolescents and youth 0 to 24 years living with perinatally acquired HIV, before and after antiretroviral therapy initiation in the paediatric IeDEA Global Cohort Consortium. J Int AIDS Soc 23, e25617. http://doi.org/10.1002/jia2.25617.

Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration. (2020). Outcomes of second-line antiretroviral therapy among children living with HIV: a global cohort analysis. J Int AIDS Soc 23, e25477. http://doi.org/10.1002/jia2.25477.

Chammartin, F. et al. (2020). International epidemiology databases to evaluate AIDS (IeDEA) in sub-Saharan Africa, 2012-2019. BMJ Open 10, e035246. http://doi.org/10.1136/bmjopen-2019-035246.

2019

Zurcher, K. et al. (2019). Diagnosis and clinical outcomes of extrapulmonary tuberculosis in antiretroviral therapy programmes in low- and middle-income countries: a multicohort study. J Int AIDS Soc 22, e25392. http://doi.org/10.1002/jia2.25392.

Zurcher, K. et al. (2019). Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study. Lancet Infect Dis 19, 298–307. http://doi.org/10.1016/S1473-3099(18)30673-X.

Yotebieng, M. et al. (2019). Research priorities to inform ‘Treat All’ policy implementation for people living with HIV in sub-Saharan Africa: a consensus statement from the International epidemiology Databases to Evaluate AIDS (IeDEA). J Int AIDS Soc 22, e25218. http://doi.org/10.1002/jia2.25218.

Vreeman, R. C. et al. (2019). Validation of a self-report adherence measurement tool among a multinational cohort of children living with HIV in Kenya, South Africa and Thailand. J Int AIDS Soc 22, e25304. http://doi.org/10.1002/jia2.25304.

Tymejczyk, O. et al. (2019). Changes in rapid HIV treatment initiation after national ‘treat all’ policy adoption in 6 sub-Saharan African countries: Regression discontinuity analysis. PLoS Med 16, e1002822. http://doi.org/10.1371/journal.pmed.1002822.

Stover, J. et al. (2019). Updates to the Spectrum/AIM model for estimating key HIV indicators at national and subnational levels. AIDS 33 Suppl 3, S227–S234. http://doi.org/10.1097/QAD.0000000000002357.

Pettit, A. C. et al. (2019). Directly observed therapy and risk of unfavourable tuberculosis treatment outcomes among an international cohort of people living with HIV in low- and middle-income countries. J Int AIDS Soc 22, e25423. http://doi.org/10.1002/jia2.25423.

Johnson, L. F. et al. (2019). Global variations in mortality in adults after initiating antiretroviral treatment: an updated analysis of the International epidemiology Databases to Evaluate AIDS cohort collaboration. AIDS 33 Suppl 3, S283–S294. http://doi.org/10.1097/QAD.0000000000002358.

Jesson, J. et al. (2019). Stunting and growth velocity of adolescents with perinatally acquired HIV: differential evolution for males and females. A multiregional analysis from the IeDEA global paediatric collaboration. J Int AIDS Soc 22, e25412. http://doi.org/10.1002/jia2.25412.

Gygli, S. M. et al. (2019). Whole-Genome Sequencing for Drug Resistance Profile Prediction in Mycobacterium tuberculosis. Antimicrob Agents Chemother 63. http://doi.org/10.1128/AAC.02175-18.

Collaborative Initiative for Paediatric & Research Global Cohort. (2019). Incidence of switching to second-line antiretroviral therapy and associated factors in children with HIV: an international cohort collaboration. Lancet HIV 6, e105–e115. http://doi.org/10.1016/S2352-3018(18)30319-9.

Brazier, E. et al. (2019). Implementation of ‘Treat-all’ at adult HIV care and treatment sites in the Global IeDEA Consortium: results from the Site Assessment Survey. J Int AIDS Soc 22, e25331. http://doi.org/10.1002/jia2.25331.

Boettiger, D. C. et al. (2019). Temporal Trends in Co-trimoxazole Use Among Children on Antiretroviral Therapy and the Impact of Co-trimoxazole on Mortality Rates in Children Without Severe Immunodeficiency. J Pediatric Infect Dis Soc 8, 450–460. http://doi.org/10.1093/jpids/piy087.

2018

Zaniewski, E. et al. (2018). IeDEA-WHO Research-Policy Collaboration: contributing real-world evidence to HIV progress reporting and guideline development. J Virus Erad 4, 9–15. https://doi.org/10.1016/S2055-6640(20)30348-4.

Wools-Kaloustian, K. et al. (2018). Time to First-Line ART Failure and Time to Second-Line ART Switch in the IeDEA Pediatric Cohort. J Acquir Immune Defic Syndr 78, 221–230. http://doi.org/10.1097/QAI.0000000000001667.

Tymejczyk, O. et al. (2018). HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries. PLoS Med 15, e1002534. http://doi.org/10.1371/journal.pmed.1002534.

Parcesepe, A. M. et al. (2018). Mental health and HIV: research priorities related to the implementation and scale up of ‘treat all’ in sub-Saharan Africa. J Virus Erad 4, 16–25. https://doi.org/10.1016/S2055-6640(20)30341-1.

Parcesepe, A. M. et al. (2018). Screening and management of mental health and substance use disorders in HIV treatment settings in low- and middle-income countries within the global IeDEA consortium. J Int AIDS Soc 21, e25101. http://doi.org/10.1002/jia2.25101

Panayidou, K. et al. (2018). Global temporal changes in the proportion of children with advanced disease at the start of combination antiretroviral therapy in an era of changing criteria for treatment initiation. J Int AIDS Soc 21, e25200. http://doi.org/10.1002/jia2.25200.

Lancaster, K. E. et al. (2018). Substance use and universal access to HIV testing and treatment in sub-Saharan Africa: implications and research priorities. J Virus Erad 4, 26–32. http://doi.org/10.1016/S2055-6640(20)30342-3.

Kariminia, A. et al. (2018). Mortality and losses to follow-up among adolescents living with HIV in the IeDEA global cohort collaboration. J Int AIDS Soc 21, e25215. http://doi.org/10.1002/jia2.25215.

IeDEA and COHERE Cohort Collaborations. (2018). Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs. Clin Infect Dis 66, 893–903. http://doi.org/10.1093/cid/cix915

Haas, A. D. et al. (2018). Retention and mortality on antiretroviral therapy in sub-Saharan Africa: collaborative analyses of HIV treatment programmes. J Int AIDS Soc 21, e25084–e25084. http://doi.org/10.1002/jia2.25084.

Giles, M. L. et al. (2018). Sex-based differences in antiretroviral therapy initiation, switching and treatment interruptions: global overview from the International Epidemiologic Databases to Evaluate AIDS (IeDEA). J Int AIDS Soc 21, e25149. http://doi.org/10.1002/jia2.25149.

Ford, N. et al. (2018). The contribution of observational studies in supporting the WHO ‘treat all’ recommendation for HIV/AIDS. J Virus Erad 4, 5–8. https://doi.org/10.1016/s2055-6640(20)30346-0.

Enane, L. A. et al. (2018). Traversing the cascade: urgent research priorities for implementing the ‘treat all’ strategy for children and adolescents living with HIV in sub-Saharan Africa. Journal of Virus Eradication 4, 40–46. http://doi.org/10.1016/s2055-6640(20)30344-7.

Desmonde, S. et al. (2018). Access to antiretroviral therapy in HIV-infected children aged 0-19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004-2015: A prospective cohort study. PLoS Medicine 15, e1002565–e1002565. http://doi.org/10.1371/journal.pmed.1002565.

Collaborative Initiative for Paediatric et al. (2018). The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis. PLoS Med 15, e1002514. http://doi.org/10.1371/journal.pmed.1002514.

Cipher Global Cohort Collaboration. (2018). Inequality in outcomes for adolescents living with perinatally acquired HIV in sub-Saharan Africa: a Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Cohort Collaboration analysis. J Int AIDS Soc 21 Suppl 1, e25044–e25044. http://doi.org/10.1002/jia2.25044.

Arrive, E. et al. (2018). Models of support for disclosure of HIV status to HIV-infected children and adolescents in resource-limited settings. J Int AIDS Soc 21, e25157. http://doi.org/10.1002/jia2.25157.

Aids-defining Cancer Project Working Group of IeDEA, (2018). Non-Hodgkin lymphoma risk in adults living with HIV across five continents. AIDS 32, 2777–2786. http://doi.org/10.1097/QAD.0000000000002003.

2017

Semeere, A. et al. (2017). Updating vital status by tracking in the community among patients with epidemic Kaposi sarcoma who are lost to follow-up in sub-Saharan Africa. BMC Cancer 17, 611. http://doi.org/10.1186/s12885-017-3549-1.

Jiamsakul, A. et al. (2017). HIV Viral Load Suppression in Adults and Children Receiving Antiretroviral Therapy-Results From the IeDEA Collaboration. J Acquir Immune Defic Syndr 76, 319–329. http://doi.org/10.1097/QAI.0000000000001499.

IeDEA Pediatric Working Group. (2017). Taking a critical look at the UNAIDS global estimates on paediatric and adolescent HIV survival and death. J Int AIDS Soc 20, 21952. http://doi.org/10.7448/IAS.20.1.21952.

Fritz, C. Q. et al. (2017). Comprehensiveness of HIV care provided at global HIV treatment sites in the IeDEA consortium: 2009 and 2014. J Int AIDS Soc 20, 20933. http://doi.org/10.7448/IAS.20.1.20933.

Coffie, P. A. et al. (2017). Trends in hepatitis B virus testing practices and management in HIV clinics across sub-Saharan Africa. BMC Infect Dis 17, 706. http://doi.org/10.1186/s12879-017-2768-z.

Clouse, K. et al. (2017). Low implementation of Xpert MTB/RIF among HIV/TB co-infected adults in the International epidemiologic Databases to Evaluate AIDS (IeDEA) program. PLoS One 12, e0171384. http://doi.org/10.1371/journal.pone.0171384.

Carlucci, J. G. et al. (2017). Tuberculosis Treatment Outcomes Among HIV/TB-Coinfected Children in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Network. J Acquir Immune Defic Syndr 75, 156–163. http://doi.org/10.1097/QAI.0000000000001335.

Brown, S. A. et al. (2017). Brief Report: Pediatric Cancer Burden and Treatment Resources Within the Pediatric IeDEA Consortium. JAIDS Journal of Acquired Immune Deficiency Syndromes 76, 60–64. http://doi.org/10.1097/QAI.0000000000001453.

Brennan, A. T. et al. (2017). Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa? AIDS 31, 147–157. http://doi.org/10.1097/QAD.0000000000001307.

Anderegg, N. et al. (2017). All-cause mortality in HIV-positive adults starting combination antiretroviral therapy: correcting for loss to follow-up. AIDS 31 Suppl 1, S31–S40. http://doi.org/10.1097/QAD.0000000000001321.

AIDS-defining Cancer Project Working Group for IeDEA and COHERE in EuroCoord. (2017). Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 65, 1316–1326. http://doi.org/10.1093/cid/cix480.

2016

Rachlis, B. et al. (2016). Targeted Spontaneous Reporting: Assessing Opportunities to Conduct Routine Pharmacovigilance for Antiretroviral Treatment on an International Scale. Drug Saf 39, 959–76. http://doi.org/10.1007/s40264-016-0434-9.

Freeman, E. et al. (2016). Pitfalls of practicing cancer epidemiology in resource-limited settings: the case of survival and loss to follow-up after a diagnosis of Kaposi’s sarcoma in five countries across sub-Saharan Africa. BMC Cancer 16, 65. http://doi.org/10.1186/s12885-016-2080-0.

Charles, M. K. et al. (2016). Implementation of Tuberculosis Intensive Case Finding, Isoniazid Preventive Therapy, and Infection Control (‘Three I’s’) and HIV-Tuberculosis Service Integration in Lower Income Countries. PLoS One 11, e0153243. http://doi.org/10.1371/journal.pone.0153243.

2015

Yotebieng, M. et al. (2015). Age-specific and sex-specific weight gain norms to monitor antiretroviral therapy in children in low-income and middle-income countries. AIDS 29, 101–109. http://doi.org/10.1097/QAD.0000000000000506.

Koller, M. et al. (2015). Immunodeficiency in children starting antiretroviral therapy in low-, middle-, and high-income countries. J Acquir Immune Defic Syndr 68, 62–72. http://doi.org/10.1097/QAI.0000000000000380.

Koller, M. et al. (2015). Authors’ Reply: Early Initiation of Antiretroviral Therapy Among Young Children: A Long Way to Go. J Acquir Immune Defic Syndr 70, e71-2. http://doi.org/10.1097/QAI.0000000000000773.

Huisin ’t Veld, D. et al. (2015). Determinants of Weight Evolution Among HIV-Positive Patients Initiating Antiretroviral Treatment in Low-Resource Settings. J Acquir Immune Defic Syndr 70, 146–54. http://doi.org/10.1097/QAI.0000000000000691.

Haas, A. D. et al. (2015). Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis. Lancet HIV 2, e271-8. http://doi.org/10.1016/S2352-3018(15)00087-9.

Geng, E. H. et al. (2015). CD41 T cell recovery during suppression of HIV replication: an international comparison of the immunological efficacy of antiretroviral therapy in North America, Asia and Africa. Int J Epidemiol 44, 251–263. http://doi.org/10.1093/ije/dyu271.

Ballif, M. et al. (2015). Tuberculosis in Pediatric Antiretroviral Therapy Programs in Low- and Middle-Income Countries: Diagnosis and Screening Practices. J Pediatric Infect Dis Soc 4, 30–8. http://doi.org/10.1093/jpids/piu020.

2014

IeDEA and ART Cohort Collaborations et al. (2014). Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries. J Acquir Immune Defic Syndr 65, e8-16. http://doi.org/10.1097/QAI.0b013e3182a39979.

Duda, S. N. et al. (2014). Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia-Pacific, sub-Saharan Africa and the Americas: results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration. J Int AIDS Soc 17, 19045. http://doi.org/10.7448/IAS.17.1.19045

Ballif, M. et al. (2014). Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries. Int J Tuberc Lung Dis 18, 1327–36. http://doi.org/10.5588/ijtld.14.0106.

2013

Leroy, V. et al. (2013). Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration. J Acquir Immune Defic Syndr 62, 208–219. http://doi.org/10.1097/QAI.0b013e31827b70bf.

IeDEA Pediatric Working Group. (2013). A survey of paediatric HIV programmatic and clinical management practices in Asia and sub-Saharan Africa–the International epidemiologic Databases to Evaluate AIDS (IeDEA). J Int AIDS Soc 16, 17998. http://doi.org/10.7448/IAS.16.1.17998.

Fenner, L. et al. (2013). Tuberculosis in antiretroviral treatment programs in lower income countries: availability and use of diagnostics and screening. PLoS One 8, e77697. http://doi.org/10.1371/journal.pone.0077697.

2012

Zhou, J. et al. (2012). Short-term risk of anaemia following initiation of combination antiretroviral treatment in HIV-infected patients in countries in sub-Saharan Africa, Asia-Pacific, and central and South America. J Int AIDS Soc 15, 5. http://doi.org/10.1186/1758-2652-15-5

Yiannoutsos, C. T. et al. (2012). Estimated mortality of adult HIV-infected patients starting treatment with combination antiretroviral therapy. Sex Transm Infect 88 Suppl 2, i33-43. http://doi.org/10.1136/sextrans-2012-050658.

Calmy, A. et al. (2012). Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settings. BMC Infect Dis 12, 147. http://doi.org/10.1186/1471-2334-12-147.

2011

Egger, M. et al. (2011). Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-Saharan Africa. PLoS Med 8, e1000390. http://doi.org/10.1371/journal.pmed.1000390.

Chi, B. H. et al. (2011). Universal definition of loss to follow-up in HIV treatment programs: a statistical analysis of 111 facilities in Africa, Asia, and Latin America. PLoS Med 8, e1001111. http://doi.org/10.1371/journal.pmed.1001111.

2010

Brinkhof, M. W. et al. (2010). Adjusting mortality for loss to follow-up: analysis of five ART programmes in sub-Saharan Africa. PLoS One 5, e14149. http://doi.org/10.1371/journal.pone.0014149.

Multi-regional

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

Global Newsletter – January

Global Newsletter – November

Global Newsletter – September

Global Newsletter – July

Global Newsletter – April